We characterized multidrug-resistant Pseudomonas aeruginosa strains isolated from patients involved in an outbreak of catheter-associated urinary tract infections that occurred in a neurosurgery ward of a hospital in Sendai, Japan. Pulsed-field gel electrophoresis of SpeI-, XbaI-, or HpaI-digested genomic DNAs from the isolates revealed that clonal expansion of a P. aeruginosa strain designated IMCJ2.S1 had occurred in the ward. This strain possessed broad-spectrum resistance to aminoglycosides, ␤-lactams, fluoroquinolones, tetracyclines, sulfonamides, and chlorhexidine. Strain IMCJ2.S1 showed a level of resistance to some kinds of disinfectants similar to that of a control strain of P. aeruginosa, ATCC 27853. IMCJ2.S1 contained a novel class 1 integron, In113, in the chromosome but not on a plasmid. In113 contains an array of three gene cassettes of bla IMP-1 , a novel aminoglycoside resistance gene, and the aadA1 gene. The aminoglycoside resistance gene, designated aac(6)-Iae, encoded a 183-amino-acid protein that shared 57.1% identity with AAC(6)-Iq. Recombinant AAC(6)-Iae protein showed aminoglycoside 6-N-acetyltransferase activity by thin-layer chromatography. Escherichia coli expressing exogenous aac(6)-Iae showed resistance to amikacin, dibekacin, isepamicin, kanamycin, netilmicin, sisomicin, and tobramycin but not to arbekacin, gentamicins, or streptomycin. Alterations of gyrA and parC at the amino acid sequence level were detected in IMCJ2.S1, suggesting that such mutations confer the resistance to fluoroquinolones observed for this strain. These results indicate that P. aeruginosa IMCJ2.S1 has developed multidrug resistance by acquiring resistance determinants, including a novel member of the aac(6)-I family and mutations in drug resistance genes.
Pseudomonas aeruginosa is intrinsically resistant to many antibiotics; however, it is sensitive to a limited number of drugs, including some ␤-lactams, such as ceftazidime and imipenem, and aminoglycosides, such as amikacin and tobramycin. However, recent studies have shown that several strains of P. aeruginosa that are resistant to these antibiotics have emerged and are becoming widespread (21, 28) .
In Japan, the major mechanism of resistance to aminoglycosides is production of aminoglycoside-modifying enzymes (43) . The aminoglycoside 6Ј-N-acetyltransferases [AAC(6Ј)s] are of particular interest because they can modify a number of clinically important aminoglycosides including amikacin, gentamicin, netilmicin, and tobramycin. The AAC(6Ј)-I type confers resistance to amikacin through acetylation of the drug, whereas the AAC(6Ј)-II type acetylates gentamicin.
To date, several different genes, designated aac(6Ј)-Ia to aac(6Ј)-Iad, that encode the AAC(6Ј)-I enzymes have been cloned and characterized (42, 50) . Genes encoding aminoglycoside-modifying enzymes are often located on integrons (15) , sequences that can integrate gene cassettes through site-specific recombination (17) , in both plasmid and genomic DNA (15) . Class 1 integrons participate in multidrug resistance in P. aeruginosa (27, 28, 37) . Class 1 integrons contain two conserved segments (CS) that flank the antibiotic resistance gene cassettes. The 5Ј-CS contains the intI1 gene, which encodes integrase, the enzyme responsible for catalysis of site-specific recombination (8) . The 3Ј-CS contains the qacE⌬1 and sul1 genes and an open reading frame (ORF), orf5 (13, 16) .
We describe here the genotypic and phenotypic properties of a new multidrug-resistant P. aeruginosa strain that caused a nosocomial outbreak of infection at a hospital in Japan. The isolate carries a class 1 integron that contains an array of three gene cassettes, including one encoding a novel aminoglycoside acetyltransferase.
DNA sequencing. DNA sequences were determined by the dideoxy chain termination method with an ABI PRISM 3100 sequencer (Applied Biosystems). Homology searches of nucleotide and deduced protein sequences were performed by FASTA and BLAST screens of the DDBJ, GenBank, and EMBL databases. Multiple-sequence alignments and searches for ORFs were performed with GENETYX-WIN software (Genetyx, Tokyo, Japan). The dendrogram for AACs was calculated with the CLUSTAL W Program (49) .
Cloning of the aac(6)-Iae gene. The coding region of aac(6Ј)-Iae ( Fig. 1 ) was amplified by PCR with 2.5 U of Ex Taq DNA polymerase (Takara Bio) and primers aacS1-FC and aacS1-RC (Table 1 ). The PCR products were cloned into pCRT7/NT (Invitrogen) downstream of the region encoding a six-His tag. Then plasmid pAAC6, which contains aac(6Ј)-Iae, or plasmid pREVAAC6, which contains aac(6Ј)-Iae in the reverse direction, was transformed into E. coli DH5␣ cells by the CaCl 2 method (6). DNA sequences of these cloned fragments were verified by sequencing of both strands as described above.
Purification of recombinant AAC(6)-Iae. E. coli BL21-AI harboring plasmid pAAC6 was grown to an A 600 of 0.2 to 0.3 in LB medium containing 50 mg/liter ampicillin at 37°C. After addition of arabinose (final concentration, 0.02%) to induce expression of AAC(6Ј)-Iae, the E. coli strain was cultured for another 18 h at 25°C. The bacterial cells were collected, resuspended in 50 mM HEPES buffer (pH 7.5) containing 0.1% Triton X-100, and lysed by sonication on ice for 15 s 40 times and then for 20 s 100 times. After centrifugation to remove the debris, the solubilized protein was applied to an AKTA Prime (Amersham Biosciences, Piscataway, NJ) system equipped with a HiTrap Chelating HP column (Amersham Biosciences) loaded with Ni 2ϩ . The column was washed with 20 mM Tris-HCl (pH 7.9) containing 60 mM imidazole and 0.5 M NaCl and was eluted with the same buffer containing 1 M imidazole. The eluted proteins were collected and dialyzed in 50 mM HEPES buffer (pH 7.5). The protein preparation yielded a single band upon sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis (data not shown).
Acetylation of aminoglycosides by recombinant ACC(6)-Iae. Enzymatic acetylation of aminoglycosides was done as described previously (53) . Recombinant AAC(6Ј) from actinomycete strain #8 was provided by J. Ishikawa (National Institute of Infectious Diseases, Tokyo, Japan). Various aminoglycosides were incubated with recombinant AAC(6Ј)-Iae or AAC(6Ј) as a positive control in the presence of acetyl coenzyme A, and the acetylated derivatives were detected by thin-layer chromatography. The reaction was carried out at 37°C for 30 min to 12 h.
Pulsed-field gel electrophoresis (PFGE). Genomic DNA from P. aeruginosa was prepared by the procedure of Grundmann et al. (14) and digested overnight with 10 U of SpeI, XbaI, or HpaI (Takara Bio). The DNA fragments were separated on 1.0% agarose gels in 0.5ϫ Tris-borate-EDTA buffer with a CHEF Mapper system (Bio-Rad Laboratories, Hercules, Calif.) at 6 V/cm for 20 h.
Southern hybridization. We performed Southern blotting to identify the location of In113. A 465-bp segment of aac(6Ј)-Iae and a 362-bp segment of bla IMP-1 amplified by PCR were labeled with horseradish peroxidase and used as probes.
Nucleotide sequence accession number. The nucleotide sequence of In113 reported here has been deposited in the EMBL/GenBank/DDBJ databases and assigned accession number AB104852.
RESULTS
Epidemiologic analysis of a nosocomial outbreak of P. aeruginosa. From June 2002 to November 2002, a P. aeruginosa outbreak occurred in a neurosurgery ward of a 500-bed hospital in Japan. Three patients developed catheter-associated urinary tract infections with multidrug-resistant P. aeruginosa in June 2002. Various measures for infection control were undertaken, but four patients subsequently developed similar catheter-associated urinary tract infections with multidrug-resistant P. aeruginosa over the next 5 months. Seven P. aeruginosa isolates from these patients were analyzed by PFGE. The PFGE patterns of SpeI-, XbaI-, or HpaI-digested genomic DNAs from the isolates were identical, indicating that the isolates were all from monoclonal expansion of a single multidrug-resistant P. aeruginosa strain. This clone was named P. aeruginosa IMCJ2.S1. PFGE patterns of SpeI-, XbaI-, and VOL. 49, 2005 CHARACTERIZATION OF aac(6Ј)-Iae GENE 3735
HpaI-digested genomic DNAs from IMCJ2.S1 are shown in Fig. 2A . Susceptibility of P. aeruginosa IMCJ2.S1 to antibiotics and disinfectants. The MICs of various antibiotics, including potent active ␤-lactams, against IMCJ2.S1 were compared with those against a reference strain, P. aeruginosa ATCC 27853 (Table 2 ). IMCJ2.S1 was resistant to all antibiotics tested except for arbekacin and polymyxin B. Strain ATCC 27853 was sensitive to all of the antibiotics tested except cefoxitin, flomoxef, and kanamycin. Thus, IMCJ2.S1 was classified as a multidrug-resistant strain of P. aeruginosa.
To test whether IMCJ2.S1 showed increased resistance to disinfectants, the MBCs of four disinfectants, povidone iodine, alkyldiaminoethylglycine hydrochloride, benzalkonium chloride, and chlorhexidine gluconate, were determined for both IMCJ2.S1 and ATCC 27853. Both strains were resistant to chlorhexidine gluconate but sensitive to povidone iodine (MBC, Ͻ0.001% [wt/vol]), alkyldiaminoethylglycine hydrochloride (MBC, Ͻ0.001% [wt/vol]), and benzalkonium choride (MBC, Ͻ0.005% [wt/vol]). The MBC patterns of these strains were identical. These results indicate that the sensitivity of IMCJ2.S1 to disinfectants is not different from that of the P. aeruginosa reference strain.
Detection of an integron in P. aeruginosa IMCJ2.S1. To determine if strain IMCJ2.S1 carried a class 1 integron, PCR analysis specific for class 1 integrons was performed (29) . Strain IMCJ2.S1 yielded a 2.5-kbp PCR product, whereas E. coli CSH2 harboring plasmid NR1 (32), which carries In2 (30), yielded a 1.0-kbp PCR product. P. aeruginosa ATCC 27853 did not yield PCR products. These results suggest that strain IMCJ2.S1 and E. coli CSH2 each carry a class 1 integron and that this integron contains additional sequences that are not present in In2.
The class 1 integron frequently contains the tniB and tniA genes downstream of the 3Ј-CS (13, 16) . To confirm the presence of a class 1 integron in IMCJ2.S1 and to elucidate the c Primer designed to amplify bla IMP-1 (accession no. AB070224) or homologous genes, including bla IMP-2 (AJ243491), bla IMP-3 (AB010417), bla IMP-4 (AF445082), bla IMP-5 (AF290912), bla IMP-6 (AB040994), bla IMP-7 (AF416736), bla IMP-8 (AF322577), bla IMP-9 (AY033653), bla IMP-10 (AB074434), and bla IMP-11 (AB074437). structure downstream of the 3Ј-CS, we performed PCR specific for intI1, qacE⌬1, sul1, and their spanning or marginal regions. PCRs yielded the expected products (Table 1) , with the exception of a 4.7-kbp fragment after amplification with int-R and sul-R and a 2.5-kbp fragment after amplification with tniB-F and tniA-R. These data show that IMCJ2.S1 carries a class 1 integron and that this integron contains intI1-sul1 in a 4.7-kbp region, sul1-tniB in a 6.5-kbp region, and tniB-tniA in a 2.5-kbp region (Fig. 1) .
Identical results were obtained for the other six isolates from the outbreak.
Structure of the class 1 integron found in P. aeruginosa IMCJ2.S1. We analyzed the sequences of the PCR products to determine the structure of the class 1 integron of IMCJ2.S1. The 5Ј-CS contained intI1, the attI1 recombination site with a 7-bp core site sequence of GTTAGAA (45) , and the TGGACA (Ϫ35) and TAAACT (Ϫ10) hexamers separated by 17 bp, which is characteristic of the Pc promoter (7, 45) . Although TTGTTA (Ϫ35) and TACAGT (Ϫ10) hexamers separated by 14 bp were present again downstream of the Pc promoter, this region is not likely to act as the P2 promoter, because there is no GGG sequence (7, 45) .
Between the 5Ј-CS and 3Ј-CS, there were three gene cassettes (Fig. 1) . The 880-nucleotide (nt) cassette contained the metallo-␤-lactamase gene bla IMP-1 (35) and a 127-nt 59-base element (59-be) site, a site for site-specific cointegration events (Fig. 3) , and this cassette was identical to one described previously (2, 35) . The 647-nt cassette contained an ORF and a 68-nt 59-be site (Fig. 3) . The sequence of this 647-nt cassette was not found in any database, and therefore, we named this integron In113 (Fig. 1) . The ORF in the 647-nt cassette encoded a 183-amino-acid (aa) product that was 55.2% identical to a 6Ј-N-aminoglycoside acetyltransferase, AAC(6Ј)-Ia (48), and 57.1% identical to AAC(6Ј)-Iq of Klebsiella pneumoniae (4). We named the predicted protein AAC(6Ј)-Iae according to the standard nomenclature (42) .
AAC ( (Fig. 4) . On the basis of the work of Neuwald and Landsman (34), four motifs in the amino acid sequences of the subfamily proteins belonging to AAC(6Ј)-Iae were designated motifs C, D, A, and B (Fig. 5) . Comparison of amino acid sequences of members of the AAC(6Ј)-I subfamily with that of AAC(6Ј)-Iae revealed that motifs C, D, A, and B, which are found in most GCN5-related N-acetyltransferases (GNATs) (12, 34) , were conserved in AAC(6Ј)-Iae (Fig. 5) . A large motif at the C terminus, motif B (12), was 63.3% identical between AAC(6Ј)-Im (19) and AAC(6Ј)-Iae. The third cassette was 856 nt long and contained the aminoglycoside 3Љ-adenyltransferase gene aadA1 (18, 22) and a 60-nt 59-be site (Fig. 3) . This cassette was similar to one reported previously (30, 36) except for a silent C-to-T substitution at nt 135. The 3Ј-CS included qacE⌬1 (39), sul (47) , and orf5 (30, 37). There were three inserted sequences (IS), IS1326 (3), IS1353 (3), and IS26 (38) , in the region downstream of the 3Ј-CS (Fig.  1) . IS26 is known to be inserted into the tniA coding region of the tni transposition module (30) .
Drug resistance mediated by the AAC(6)-Iae enzyme. To examine the role of AAC(6Ј)-Iae in aminoglycoside resistance, a recombinant plasmid, pAAC6, carrying aac(6Ј)-Iae from strain IMCJ2.S1 was transformed into E. coli DH5␣. E. coli harboring pAAC6 showed significantly lower susceptibility to on July 9, 2017 by guest http://aac.asm.org/ amikacin, dibekacin, isepamicin, kanamycin, netilmicin, sisomicin, and tobramycin than the parent strain and the negative control. MICs for other aminoglycosides, including arbekacin, gentamicin, and streptomycin, were unchanged (Table 3) . These results indicate that aac(6Ј)-Iae is involved in aminoglycoside resistance. To examine potential acetylase activity of AAC(6Ј)-Iae, we assessed the purified recombinant AAC(6Ј)-Iae against aminoglycosides by thin-layer chromatography (53) . As shown in Fig. 6 , kanamycin, amikacin, tobramycin, netilmicin, sisomicin, isepamicin, arbekacin, neomycin, and gentamicin were acetylated by AAC(6Ј)-Iae and AAC(6Ј). Acetylation by AAC(6Ј)-Iae was complete for all of these aminoglycosides except gentamicin, which showed incomplete acetylation. These aminoglycosides all have 6Ј-NH 2 . The present results, therefore, suggest that AAC(6Ј)-Iae is a functional acetyltransferase that modifies the 6Ј-NH 2 position of aminoglycosides.
Location of In113. Clinical isolates of P. aeruginosa frequently possess the R plasmid, which carries a class 1 integron. Therefore, we screened our seven P. aeruginosa clinical isolates for the presence of this plasmid. P. aeruginosa GN17203 was used as a positive control for bla IMP-1 , since it has been shown to harbor pMS350, which contains a bla IMP-1 gene. Genomic DNA from IMCJ2.S1 was used as a control for aac(6Ј)-Iae and bla IMP-1 .
The extracts from the seven clinical isolates and P. aeruginosa GN17203 were separated by agarose gel electrophoresis, and Southern blotting with aac(6Ј)-Iae or bla IMP-1 as a probe was performed. A plasmid that contained bla IMP-1 but not aac(6Ј)-Iae was detected in P. aeruginosa GN17203. Despite repeated attempts (three times per procedure), we did not detect this plasmid by ethidium bromide staining or Southern blotting in any of the clinical isolates (data not shown). In contrast, Southern hybridization of SpeI-, XbaI-, and HpaIdigested genomic DNAs of the seven clinical isolates revealed 50-kb, 250-kb, and 60-kb aac(6Ј)-Iae-positive fragments, respectively (Fig. 2) . These fragments were also positive for bla IMP-1 (data not shown). To examine whether the drug-resistant phenotype of P. aeruginosa IMCJ2.S1 can be transferred by conjugation, IMCJ2.S1 was incubated with P. aeruginosa ATCC 27853 RFP r . Carbapenem resistance was transferred from P. aeruginosa GN17203 to P. aeruginosa ATCC 27853 RFP r , consistent with the results reported by Watanabe et al. (51) . In contrast, resistance to amikacin or carbapenem was not transferred from IMCJ2.S1 to ATCC 27853 RFP r . These results suggest that In113 is located in the chromosome, and not on a plasmid, of P. aeruginosa IMCJ2.S1.
Resistance of IMCJ2.S1 to fluoroquinolones. IMCJ2.S1 was highly resistant to fluoroquinolones (Table 2 ). This resistance is typically associated with mutations in the QRDR within gyrA, gyrB, parC, and parE, which encode DNA gyrase or topoisomerase IV in P. aeruginosa (1, 21, 26, 31) . Therefore, we screened IMCJ2.S1 mutations within the QRDR. Compared to the gyrA sequence of strain PAO1 (46) , the gyrA sequence of IMCJ2.S1 contained an ACC-to-ATC mutation in codon 83 that causes a Thr-to-Ile change in the A subunit of DNA gyrase. IMCJ2.S1 also had a TCG-to-TTG mutation in codon 87 of parC that causes a Ser-to-Leu substitution in the C subunit of topoisomerase IV. IMCJ2.S1 had four mutations in gyrB: CGC to CGT in codon 396, AAA to AAG in codon 408, GAA to GAG in codon 484, and TTG to CTG in codon 513. There were four mutations in parE: GAA to GAG in codon 448, GGT to GGC in codon 472, AGT to AGC in codon 474, and GCC to GCT in codon 477. These mutations in gyrB and parE did not lead to amino acid changes in the proteins encoded (1, 31) . Identical results were obtained with the other six clinical isolates. Together, these results indicate that IMCJ2.S1 contains mutations in gyrA and parC that are associated with its fluoroquinolone resistance.
DISCUSSION
A variety of aminoglycoside 6Ј-N-acetyltransferases have been described (Fig. 4) and classified into three subgroups (42, 50) . Recently, a new enzyme, AAC(6Ј)-Iad, which is a member of the largest subfamily, was isolated from an Acinetobacter genospecies 3 strain in Japan (10) . In the present study, we identified AAC(6Ј)-Iae, which shows considerable phylogenetic distance from members of the largest subfamily, which includes AAC(6Ј)-Iad and its divergents (Fig. 4) . AAC(6Ј)-Iae belongs to the subfamily comprising AAC(6Ј)-Ia, -Ii, -Im, and -Iq (4, 9, 19, 48) . There was only a low level of homology between the 59-be site of aac(6Ј)-Iae and those of the genes encoding other members of the aac(6Ј)-I family. Furthermore, aac(6Ј)-Iae has a low GϩC content (26.8%) (data not shown), whereas the average GϩC content of the P. aeruginosa PAO1 genome is 66.6% (46) . Therefore, aac(6Ј)-Iae may be derived from an environmental species with an intrinsically low GϩC content.
AAC(6Ј)-Iae from P. aeruginosa strain IMCJ2.S1, which was responsible for an outbreak of catheter-associated urinary tract infections, acetylated all of the aminoglycosides with 6Ј-NH 2 , and acetylation of arbekacin and neomycin appeared to be complete (Fig. 6I) . However, E. coli DH5␣(pAAC6), expressing exogenous AAC(6Ј)-Iae, was sensitive to arbekacin and did not show reduced susceptibility to neomycin. Arbekacin and neomycin were shown to retain their antibiotic effects even after they were acetylated by AAC(6Ј) from an arbekacinresistant actinomycete strain at the 6Ј positions (53) . Enterococcus faecium producing AAC(6Ј)-Ii was susceptible to neomycin even though AAC(6Ј)-Ii acetylated neomycin (52) . These results suggest that acetylation of arbekacin and neomycin at 6Ј positions does not affect the antimicrobial activities of these drugs. We cannot exclude the possibility that the antimicrobial activity observed after treatment with AAC(6Ј)-Iae is due to residual arbekacin or neomycin that was not acetylated.
E. coli DH5␣ expressing AAC(6Ј)-Iae was sensitive to gentamicin (Table 3) , although AAC(6Ј)-Iae showed only partial acetylation of gentamicin (Fig. 6I) . The sensitivity of these bacteria to gentamicin appears to be due to incomplete acetylation of gentamicin, which was observed with AAC(6Ј) from an arbekacin-resistant actinomycete strain (53) (Fig.6II) . Commercially available gentamicin is a mixture of a number of derivatives of gentamicin, such as gentamicin C 1 , C 1a , C 2 , and C 2b , that have modifications of position 6Ј. Gentamicin C 1 and C 2b carry a methyl group on N-6Ј and are refractory to AAC(6Ј)-I enzymes (42, 50) . We cannot exclude the possibility that acetylated gentamicin components, which are more susceptible to AAC(6Ј)-I enzymes, retain antibiotic activity.
In the present study, we identified In113, a class 1 integron that contains a novel aminoglycoside resistance gene, aac(6Ј)-Iae. Several classes of integrons have been categorized on the basis of the structure of integrase (15, 40) . The most common integrons in P. aeruginosa are those of class 1 (27, 28, 37). Because their structures are very similar to each other, the direct origin of In113 could be from In2 (30), which was originally isolated from Shigella flexneri in Japan in the late 1950s (32) (Fig. 1) . IMCJ2.S1 was resistant to all antibiotics tested except arbekacin and polymyxin B (Table 2) . However, the presence of In113 and the mutations in gyrA and parC of the QRDR are not sufficient to explain the multidrug resistance of this strain. Alterations of gyrA and parC are known to contribute to fluoroquinolone resistance (1, 21, 26, 31) . The bla IMP-1 gene cassette, which encodes the IMP-1 metallo-␤-lactamase, confers resistance to all ␤-lactams except monobactams (2, 27, 35) . The aac(6Ј)-Iae gene cassette, which encodes AAC(6Ј)-Iae, confers resistance to amikacin, dibekacin, isepamicin, kanamycin, netilmicin, sisomicin, and tobramycin ( Table 3 ). The variant aadA1 gene cassette, which encodes aminoglycoside 3Љ-adenylyltransferase, confers resistance to streptomycin (18, 22) . The sul1 gene, which encodes dihydropteroate synthetase type I, confers resistance to sulfamethoxazole (47) . Thus, the resistance of IMCJ2.S1 to aztreonam, gentamicin, tetracycline, trimethoprim, and silver sulfadiazine appears to be related to another, unidentified resistance factor(s).
In conclusion, we describe here a novel aminoglycoside 6Ј-N-acetyltransferase gene contained on a class 1 integron in a P. aeruginosa strain that caused a nosocomial outbreak of urinary tract infections. In113 may spread across Japan, because ␤-lactams, including carbapenems and aminoglycosides, are frequently used as therapeutic agents against P. aeruginosa and methicillin-resistant Staphylococcus aureus (20, 23) . Surveillance for multidrug-resistant P. aeruginosa containing In113 is under way at several medical care facilities in the Sendai area of Japan.
